siga technologies inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports siga technologies inc  product pipeline review   siga technologies inc  product pipeline review   wgr  september  global  pages global markets direct description table of content sample report enquiry before buy related reports siga technologies inc  product pipeline review   summary global markets direct’s ‘siga technologies inc  product pipeline review  ’ provides an overview of the siga technologies inc’s pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of siga technologies inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of siga technologies inc including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of siga technologies inc’s human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the siga technologies inc’s pipeline products reasons to buy  evaluate siga technologies inc’s strategic position with total access to detailed information on its product pipeline  assess the growth potential of siga technologies inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the siga technologies inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of siga technologies inc and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of siga technologies inc  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of siga technologies inc and identify potential opportunities in those areas  avoid intellectual property rights related issues table of contents table of contents  list of tables  list of figures  siga technologies inc snapshot  siga technologies inc overview  key information  key facts  siga technologies inc  research and development overview  key therapeutic areas  siga technologies inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  siga technologies inc  pipeline products glance  siga technologies inc  late stage pipeline products  phase iii productscombination treatment modalities  siga technologies inc  early stage pipeline products  indcta filed productscombination treatment modalities  preclinical productscombination treatment modalities  discovery productscombination treatment modalities  siga technologies inc  drug profiles  tecovirimat  product description  mechanism of action  rd progress  st  product description  mechanism of action  rd progress  st  product description  mechanism of action  rd progress  st  product description  mechanism of action  rd progress  st  product description  mechanism of action  rd progress  st  product description  mechanism of action  rd progress  siga technologies inc  pipeline analysis  siga technologies inc  pipeline products by target  siga technologies inc  pipeline products by route of administration  siga technologies inc  pipeline products by molecule type  siga technologies inc  pipeline products by mechanism of action  siga technologies inc  recent pipeline updates  siga technologies inc  dormant projects  siga technologies inc  locations and subsidiaries  head office  other locations  subsidiaries  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables siga technologies inc key information  siga technologies inc key facts  siga technologies inc  pipeline by indication   siga technologies inc  pipeline by stage of development   siga technologies inc  monotherapy products in pipeline   siga technologies inc  phase iii   siga technologies inc  indcta filed   siga technologies inc  preclinical   siga technologies inc  discovery   siga technologies inc  pipeline by target   siga technologies inc  pipeline by route of administration   siga technologies inc  pipeline by molecule type   siga technologies inc  pipeline products by mechanism of action   siga technologies inc  recent pipeline updates   siga technologies inc  dormant developmental projects  siga technologies inc other locations  list of figures siga technologies inc  pipeline by top  indication   siga technologies inc  pipeline by stage of development   siga technologies inc  monotherapy products in pipeline   siga technologies inc  pipeline by top  target   siga technologies inc  pipeline by top  route of administration   siga technologies inc  pipeline by top  molecule type   siga technologies inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send siga search go about sigaoverviewfacilitiesbusiness developmentofficers and board of directorscareersproduct candidatesresearch  discoverydenguegovernment relationsagencies and activitiesus and foreign marketsresourcesmedia contactsiga publicationsinvestor relationspress releasesevents  presentationscorporate governancefinancial informationstock informationinvestor faqsinvestor contactcontact us welcome to siga technologies we are a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats our lead product is tpoxx® usan tecovirimat st® an orally administered antiviral drug that targets orthopoxvirus infections while tpoxx is not yet approved as safe or effective by the us food  drug administration it is a novel smallmolecule drug that is being delivered to the us strategic national stockpile “sns” under the project bioshield act of  “project bioshield” our lead product candidate tpoxx® siga believes that tpoxx® usan tecovirimat st® is among the first new smallmolecule drugs delivered to the strategic stockpile under project bioshield tpoxx is an investigational product that is not currently approved by the fda as a treatment of orthopoxvirus infections such as smallpox or any other indication nevertheless the fda has designated tpoxx for “fasttrack” status creating a path for expedited fda review and eventual regulatory approval tpoxx is a novel patented oral drug that is easy to store transport and administer there could be several potential uses for an effective antiviral drug to treat orthopoxvirus infections to reduce mortality and morbidity in those infected with the smallpox or another orthopoxvirus virus to protect the nonimmune who risk developing smallpox following virus exposure and as an adjunct to the smallpox vaccine in order to reduce the frequency of serious adverse events due to the live virus used for vaccination on may   siga signed a contract with the biomedical advanced research and development authority barda of the us department of health and human services the “barda contract” pursuant to which siga agreed to deliver two million courses of tpoxx to the strategic national stockpile “sns” the barda contract is worth approximately  million including  million for the manufacture and delivery of  million courses of tpoxx an additional  courses are being delivered to the sns at no charge and  million of potential reimbursements the “base contract” in addition to the base contract the barda contract also contains various options that are exercisable at barda’s discretion latest news may   siga to present at the jefferies global healthcare conference on june   apr   siga completes enrollment and dosing in final cohort of phase i study of iv formulation of tpoxx® tecovirimat to treat smallpox nov   siga announces successful completion of rights offering funding of loan completion of payment of pharmathene obligation   siga technologies contact siga technologies inc  madison ave new york ny biotechnology products  services  mapquest siga technologies inc  madison ave new york ny  reviews   website menu  reservations make reservations order online tickets tickets see availability nearby directions  sponsored topics opening hours mon ampm tue ampm wed ampm thu ampm fri ampm see a problem let us know siga technologies applies microbial genomics to the design and development of novel products that prevent and treat infectious diseases as well as defend against biological warfare agents with technology platforms in both vaccines and antibiotics the company s platform technologies include a vaccine delivery system that activates the immune system at the body s mucosal surfaces in order to prevent infection at the earliest possible stage a surface protein expression system for the costeffective production of proteins biothreat rapid response therapeutics that can be rapidly designed on demand for any biological pathogen and virus counterstrike capability technology that can be used to develop safe and effective antivirals by targeting the proteinases which are encoded within all viruses siga technologies is headquartered in new york legal help siga technologies inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report siga technologies inc  product pipeline review   published by global markets direct product code  published september   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license siga technologies inc  product pipeline review   published september   content info  pages description summary global markets directs siga technologies inc  product pipeline review   provides an overview of the siga technologies incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of siga technologies incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of siga technologies inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of siga technologies incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the siga technologies incs pipeline products reasons to buy evaluate siga technologies incs strategic position with total access to detailed information on its product pipeline assess the growth potential of siga technologies inc in its therapy areas of focus identify new drug targets and therapeutic classes in the siga technologies incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of siga technologies inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of siga technologies inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of siga technologies inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures siga technologies inc snapshot siga technologies inc overview key information key facts siga technologies inc  research and development overview key therapeutic areas siga technologies inc  pipeline review pipeline products by stage of development pipeline products  monotherapy siga technologies inc  pipeline products glance siga technologies inc  late stage pipeline products phase iii productscombination treatment modalities siga technologies inc  early stage pipeline products indcta filed productscombination treatment modalities preclinical productscombination treatment modalities discovery productscombination treatment modalities siga technologies inc  drug profiles tecovirimat product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress siga technologies inc  pipeline analysis siga technologies inc  pipeline products by target siga technologies inc  pipeline products by route of administration siga technologies inc  pipeline products by molecule type siga technologies inc  pipeline products by mechanism of action siga technologies inc  recent pipeline updates siga technologies inc  dormant projects siga technologies inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables siga technologies inc key information siga technologies inc key facts siga technologies inc  pipeline by indication  siga technologies inc  pipeline by stage of development  siga technologies inc  monotherapy products in pipeline  siga technologies inc  phase iii  siga technologies inc  indcta filed  siga technologies inc  preclinical  siga technologies inc  discovery  siga technologies inc  pipeline by target  siga technologies inc  pipeline by route of administration  siga technologies inc  pipeline by molecule type  siga technologies inc  pipeline products by mechanism of action  siga technologies inc  recent pipeline updates  siga technologies inc  dormant developmental projects siga technologies inc other locations list of figures siga technologies inc  pipeline by top  indication  siga technologies inc  pipeline by stage of development  siga technologies inc  monotherapy products in pipeline  siga technologies inc  pipeline by top  target  siga technologies inc  pipeline by top  route of administration  siga technologies inc  pipeline by top  molecule type  siga technologies inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved siga technologies inc  product pipeline review    reportsnreports market research report welcome guest    registerlogin   contact us   about us      advanced search home ›  pharmaceuticals ›  report detail siga technologies inc  product pipeline review   published june  no of pages  price  single user license us   corporate user license us     report description table of contents inquire before buying global markets directs siga technologies inc product pipeline review  provides an overview of the siga technologies incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of siga technologies incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of siga technologies inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of siga technologies incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the siga technologies incs pipeline productsreasons to buyevaluate siga technologies incs strategic position with total access to detailed information on its product pipelineassess the growth potential of siga technologies inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the siga technologies incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of siga technologies inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of siga technologies incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of siga technologies inc and identify potential opportunities in those areasavoid intellectual property rights related issues siga technologies inc  product pipeline review   table of contentstable of contents list of tables list of figures siga technologies inc snapshot siga technologies inc overview key information key facts siga technologies inc  research and development overview key therapeutic areas siga technologies inc  pipeline review pipeline products by stage of development pipeline products  monotherapy siga technologies inc  pipeline products glance siga technologies inc  clinical stage pipeline products phase ii productscombination treatment modalities siga technologies inc  early stage pipeline products indcta filed productscombination treatment modalities preclinical productscombination treatment modalities discovery productscombination treatment modalities siga technologies inc  unknown stage pipeline products unknown productscombination treatment modalities siga technologies inc  drug profiles tecovirimat product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress small molecule for bunya virus product description mechanism of action rd progress small molecule for influenza virus product description mechanism of action rd progress smallpox vaccine product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress siga technologies inc  pipeline analysis siga technologies inc  pipeline products by target siga technologies inc  pipeline products by route of administration siga technologies inc  pipeline products by molecule type siga technologies inc  pipeline products by mechanism of action siga technologies inc  recent pipeline updates siga technologies inc  dormant projects siga technologies inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablessiga technologies inc key information siga technologies inc key facts siga technologies inc  pipeline by indication  siga technologies inc  pipeline by stage of development  siga technologies inc  monotherapy products in pipeline  siga technologies inc  phase ii  siga technologies inc  indcta filed  siga technologies inc  preclinical  siga technologies inc  discovery  siga technologies inc  unknown  siga technologies inc  pipeline by target  siga technologies inc  pipeline by route of administration  siga technologies inc  pipeline by molecule type  siga technologies inc  pipeline products by mechanism of action  siga technologies inc  recent pipeline updates  siga technologies inc  dormant developmental projects siga technologies inc other locations list of figuressiga technologies inc  pipeline by top  indication  siga technologies inc  pipeline by stage of development  siga technologies inc  monotherapy products in pipeline  siga technologies inc  pipeline by top  target  siga technologies inc  pipeline by top  route of administration  siga technologies inc  pipeline by top  molecule type  siga technologies inc  pipeline products by top  mechanism of action   published by global markets direct product code global markets direct did you find what you arewere looking for  if not read below and browse through other relevant pages for similar market research reports or get in touch with us through the formcontact info in your right navigation panel and well share relevant market report titles for you to explore related reports global onychomycosis tinea unguium drug detailed analysis report  this report splits onychomycosis tinea unguium drug by product drug form by product usage type this shares the history data information from  to  and forecast from  to  and this report mainly introduces volume and value marke  united states vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx fro  united states tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx from   philippines vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in philippines from the xx million usd in  with a cagr compound annual growth rate xx from   philippines tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in philippines from the xx million usd in  with a cagr compound annual growth rate xx from    malaysia vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in malaysia from the xx million usd in  with a cagr compound annual growth rate xx from   malaysia tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in malaysia from the xx million usd in  with a cagr compound annual growth rate xx from  to   japan vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in japan from the xx million usd in  with a cagr compound annual growth rate xx from  t  japan tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in japan from the xx million usd in  with a cagr compound annual growth rate xx from  to   india vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in india from the xx million usd in  with a cagr compound annual growth rate xx from  t why reportsnreportscom  market research reports and growing top fortune  organizations trust us for research data  support on call as well as emails your details are safe with us free support for your research requirements report delivery email delivery time upto  hrs  working days upto  hrs max  weekends and public holidays research support  custom research if this business study does not have the data and information analysis you need contact us with your research requirements we explore available market research reports to map your needs and share report titles with you alternatively we can also offer custom research that suits your budget and timelines share your information requirements here connect with us email salesreportsandreportscom call       home category publisher country latest reports markets discounted reports upcoming reports contact us subscription option using our subscription option you get access to market research reports and industry data of consumer goods market as per your needs get the best of consumer goods research reports by utilizing your research budgets in an optimum way more about our subscription option report alerts get email alerts about market research reports from industries and publishers of your interest please enter a valid email id thank you you have successfully subscribed to our report alerts avail upto  discount on below publisher reports technavio azoth analytics   reportsnreports all rights reserved disclamer privacy policy  terms and conditions  our market research blog  sitemap feeds rss  latest reports market report siga technologies inc  product pipeline review   about us • publishers • contact us • cart login  register all industries business  finance  business  financial services  insurance  marketing consumer  food  beverages  consumer goods  food  retailing healthcare  biotechnology  healthcare  medical devices  pharmaceuticals heavy industry  construction  energy  manufacturing  materials  transportation internet  media  ebusiness  internet  media  publishing public sector  defense  education  government telecom  computing  computer technology  fixed networks  software  wireless companycountry reports  company reports  country reports  regional reports   processing siga technologies inc  product pipeline review   sep    global markets direct   pages  usd  click here to open the popup youve added the following report to your cartclose cart summary total items subtotal      report summary table of contents companies request details related global markets directs siga technologies inc  product pipeline review   provides an overview of the siga technologies incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of siga technologies incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of siga technologies inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of siga technologies incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the siga technologies incs pipeline productsreasons to buyevaluate siga technologies incs strategic position with total access to detailed information on its product pipelineassess the growth potential of siga technologies inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the siga technologies incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of siga technologies inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of siga technologies incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of siga technologies inc and identify potential opportunities in those areasavoid intellectual property rights related issues table of contentstable of contentslist of tableslist of figuressiga technologies inc snapshotsiga technologies inc overviewkey informationkey factssiga technologies inc  research and development overviewkey therapeutic areassiga technologies inc  pipeline reviewpipeline products by stage of developmentpipeline products  monotherapysiga technologies inc  pipeline products glancesiga technologies inc  late stage pipeline productsphase iii productscombination treatment modalitiessiga technologies inc  early stage pipeline productsindcta filed productscombination treatment modalitiespreclinical productscombination treatment modalitiesdiscovery productscombination treatment modalitiessiga technologies inc  drug profilestecovirimatproduct descriptionmechanism of actionrd progressstproduct descriptionmechanism of actionrd progressstproduct descriptionmechanism of actionrd progressstproduct descriptionmechanism of actionrd progressstproduct descriptionmechanism of actionrd progressstproduct descriptionmechanism of actionrd progresssiga technologies inc  pipeline analysissiga technologies inc  pipeline products by targetsiga technologies inc  pipeline products by route of administrationsiga technologies inc  pipeline products by molecule typesiga technologies inc  pipeline products by mechanism of actionsiga technologies inc  recent pipeline updatessiga technologies inc  dormant projectssiga technologies inc  locations and subsidiarieshead officeother locations  subsidiariesappendixmethodologycoveragesecondary researchprimary researchexpert panel validationcontact usdisclaimerlist of tablessiga technologies inc key informationsiga technologies inc key factssiga technologies inc  pipeline by indication siga technologies inc  pipeline by stage of development siga technologies inc  monotherapy products in pipeline siga technologies inc  phase iii siga technologies inc  indcta filed siga technologies inc  preclinical siga technologies inc  discovery siga technologies inc  pipeline by target siga technologies inc  pipeline by route of administration siga technologies inc  pipeline by molecule type siga technologies inc  pipeline products by mechanism of action siga technologies inc  recent pipeline updates siga technologies inc  dormant developmental projectssiga technologies inc other locationslist of figuressiga technologies inc  pipeline by top  indication siga technologies inc  pipeline by stage of development siga technologies inc  monotherapy products in pipeline siga technologies inc  pipeline by top  target siga technologies inc  pipeline by top  route of administration siga technologies inc  pipeline by top  molecule type siga technologies inc  pipeline products by top  mechanism of action  companies mentioned in this reportsiga technologies inc this report does not have a press release associated with it order today format pdf  usd license single user delivery by email   business day the fast market research advantage only the best all of our research is sourced from the most trusted and established global analysts and consultancies client focused from startups to multinationals we focus on providing the right research to our diverse client base shop securely our usbased customer service team and ecommerce systems adhere to the highest data security standards industryleading customer support individualized assistance from our expert staff is never more than an email or phone call away best price guarantee we are committed to providing the best research at the lowest cost we will match any published price for the same report guaranteed easy ordering once you’ve found the right report click ‘order now’ and complete the checkout process using any major credit card check or wirebank transferneed multiuser or enterprise license pricing contact us for a custom quote about the publisher global markets direct is a leading provider of global business intelligence and market analysis it publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industryspecific information publisher details privacy policy  terms of use  flashalerts copyright copy  fast market research inc siga technologies inc  product pipeline review    rnr market research advanced search     salesrnrmarketresearchcom search market research reports ﻿ market research assistance salesrnrmarketresearchcom on the web related markets biotechnologybiomaterialsbiomarkersstem celldrug discoveryindustrial biotechnologywound careenzymemicroarraybiopharmaceuticalcell culture related market reportssiga technologies inc  product pipeline review   home  life sciences  pharmaceuticals  report detail siga technologies inc  product pipeline review   publisher name  global markets direct date jun no of pages  price single user license us  corporate user license us  report descriptiontable of contentnews  blogother reportsour offerings global markets directs siga technologies inc product pipeline review  provides an overview of the siga technologies incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of siga technologies incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of siga technologies inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of siga technologies incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the siga technologies incs pipeline products reasons to buy evaluate siga technologies incs strategic position with total access to detailed information on its product pipeline assess the growth potential of siga technologies inc in its therapy areas of focus identify new drug targets and therapeutic classes in the siga technologies incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of siga technologies inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of siga technologies inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of siga technologies inc and identify potential opportunities in those areas avoid intellectual property rights related issues siga technologies inc  product pipeline review   table of contents table of contents  list of tables  list of figures  siga technologies inc snapshot  siga technologies inc overview  key information  key facts  siga technologies inc  research and development overview  key therapeutic areas  siga technologies inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  siga technologies inc  pipeline products glance  siga technologies inc  clinical stage pipeline products  phase ii productscombination treatment modalities  siga technologies inc  early stage pipeline products  indcta filed productscombination treatment modalities  preclinical productscombination treatment modalities  discovery productscombination treatment modalities  siga technologies inc  unknown stage pipeline products  unknown productscombination treatment modalities  siga technologies inc  drug profiles  tecovirimat  product description  mechanism of action  rd progress  st  product description  mechanism of action  rd progress  st  product description  mechanism of action  rd progress  st  product description  mechanism of action  rd progress  st  product description  mechanism of action  rd progress  small molecule for bunya virus  product description  mechanism of action  rd progress  small molecule for influenza virus  product description  mechanism of action  rd progress  smallpox vaccine  product description  mechanism of action  rd progress  st  product description  mechanism of action  rd progress  st  product description  mechanism of action  rd progress  siga technologies inc  pipeline analysis  siga technologies inc  pipeline products by target  siga technologies inc  pipeline products by route of administration  siga technologies inc  pipeline products by molecule type  siga technologies inc  pipeline products by mechanism of action  siga technologies inc  recent pipeline updates  siga technologies inc  dormant projects  siga technologies inc  locations and subsidiaries  head office  other locations  subsidiaries  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables siga technologies inc key information  siga technologies inc key facts  siga technologies inc  pipeline by indication   siga technologies inc  pipeline by stage of development   siga technologies inc  monotherapy products in pipeline   siga technologies inc  phase ii   siga technologies inc  indcta filed   siga technologies inc  preclinical   siga technologies inc  discovery   siga technologies inc  unknown   siga technologies inc  pipeline by target   siga technologies inc  pipeline by route of administration   siga technologies inc  pipeline by molecule type   siga technologies inc  pipeline products by mechanism of action   siga technologies inc  recent pipeline updates   siga technologies inc  dormant developmental projects  siga technologies inc other locations  list of figures siga technologies inc  pipeline by top  indication   siga technologies inc  pipeline by stage of development   siga technologies inc  monotherapy products in pipeline   siga technologies inc  pipeline by top  target   siga technologies inc  pipeline by top  route of administration   siga technologies inc  pipeline by top  molecule type   siga technologies inc  pipeline products by top  mechanism of action   highspeed data transmission and high volume needs propel fiber optic connectors market fiber optic connectors are a substantial fragment of the global telecommunication industry optical fibers are joined using fiber optic connectors which allow the light conduction between two consecutive optical fibers an additional im…extensive use of digital technologies for diagnostic applications to boost global optical imaging market the global optical imaging system market is predicted to reach us  billion by  it is expected to grow at a stable rate and will post a cagr of more than  in the coming years the growing market infiltration of digital …foremost trends in global pet care market the global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments it is estimated that the global pet care market will grow at a cagr o…china to review its food security laws china has arisen as the globe’s firmest developing economy in addition china brags about the biggest population pool in the world in recent times the one child policy in the republic was terminated this is anticipated to upsur…improving standards of living to boost global consumer durables market consumer durables is a cataloguing of consumer goods that are not essential to be bought very often as they are fashioned in a way so as to last for an extended period of time profits in the consumer durables sector were most profoundly…  philippines vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in philippines from the xx million usd in  with a cagr compound annual growth rate xx from  to  in malaysia market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac   united states vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx from  to  in united states market the top players include coopersurgical medgyn personal medical corp integra lifesciences   top  vaginal pessary manufacturers in north america europe asiapacific south america middle east and africa published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the global vaginal pessary market size will be xx million usd in  from the xx million usd in  with a cagr compound annual growth rate xx from  to  this report studies vaginal pessary in global market especially in north america europe asiapacific south america middle east and africa focuses on the top  vaginal pessary players in each reg  china vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in china from the xx million usd in  with a cagr compound annual growth rate xx from  to  in china market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical  global top countries vaginal pessary market report published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the global vaginal pessary market size will be xx million usd in  from the xx million usd in  with a cagr compound annual growth rate xx from  to  this report studies vaginal pessary in global market especially in united states canada mexico germany france uk italy russia china japan india korea southeast asia australia brazil mi  india vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in india from the xx million usd in  with a cagr compound annual growth rate xx from  to  in india market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical  japan vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in japan from the xx million usd in  with a cagr compound annual growth rate xx from  to  in japan market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical  malaysia vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in malaysia from the xx million usd in  with a cagr compound annual growth rate xx from  to  in malaysia market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac med emea europe middle east and africa paramenthanediol pmd market report  published jul        price us  onwards        pages  in this report the emea paramenthanediolpmd market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report split emea into europe the middle east and africa with sales k mt revenue million usd market share and growth rate of paramenthanediolpmd for these regions from  to  forecast  europe germany france uk russia italy services value for money we believe in optimum utilization of available budget and resources while servicing our clients your market research requirements we keep the same approach in focus to help you get the best value for your s ever growing inventory ranging from the smallest feasible  required data datasheets data facts swot analysis company profiles etc to full research reports that help you make decisions our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than  niche sectors one stop solution need a custom research report on medical devices market require all available business intelligence on d printing industry exploring fb sector of a particular countryregion rnrmarketresearchcom is your onestopsolution to all market intelligence needs we not only offer custom research and consulting services we also bundle reports to meet your needs and help you fetch the data analysis you require for your business dedicated client engagement not limited to only finding relevant reports for you our client engagement team dedicates its efforts to understand your business need and accordingly maps available research data to help you move forward call your client engagement executive any time of your day and get your questions answered in order to make the correct business decision saving time and efforts simply share your research requirement details with us and let us do all the hard work to find required intelligence for you when you add up our one stop solution and dedicated client engagement services mentioned above you obviously know the time and effort saving you do by working with us payment flexibility working with fortune  organizations we understand the importance of being flexible for payments share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done postpurchase research support have questions after reading a report  datasheet bought through us not sure about the methodology used for data available in the research talk to us  share your questions with us and if required we will connect you with the analystsauthors of the reports and ensure you get satisfactory answers for the same need more data  analysis  reports on the topic of your researchproject the rnrmarketresearchcom team is here for you x to support you with your postpurchase requirements subscription offers  packages get in touch with us for more details  salesrnrmarketresearchcom       ad hoc pay  as  you  go  bucket subscriptions fixed cost for of reports customize  personalize as per your needs avail upto  discount on below publisher reports azoth analytics technavio pharmaceuticals market research reports on market size and competitive analysis advanced search     salesrnrmarketresearchcom search market research reports market research assistance salesrnrmarketresearchcomon the web refine resultby datelast monthlast  monthslast  monthslast yearlast  years by price  home     life sciences    pharmaceuticals pharmaceuticals market research reports the global pharmaceutical market has persistently experienced significant growth due to the everincreasing demand for novel and more effective drugs the reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth newer and more complex disease conditions ageing population and the increased prevalence of chronic and infectious diseases some of which still remain incurable and fatal such numerous unmet needs and high demand rates have triggered the boost in rd investments by key industry sectors greatly driving the growth of this industry the pharmaceutical market valued as a multibillion dollar market is undoubtedly the largest revenue generator for the life sciences industry the pharmaceutical industry can be divided into numerous market segments based on the different therapeutic areas and applications the largest segment the market for cardiovascular drugs records huge sales every year the rising world population rapview more the global pharmaceutical market has persistently experienced significant growth due to the everincreasing demand for novel and more effective drugs the reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth newer and more complex disease conditions ageing population and the increased prevalence of chronic and infectious diseases some of which still remain incurable and fatal such numerous unmet needs and high demand rates have triggered the boost in rd investments by key industry sectors greatly driving the growth of this industry the pharmaceutical market valued as a multibillion dollar market is undoubtedly the largest revenue generator for the life sciences industry the pharmaceutical industry can be divided into numerous market segments based on the different therapeutic areas and applications the largest segment the market for cardiovascular drugs records huge sales every year the rising world population rapid ageing of the same and an increased prevalence of diseases are the major factors driving growth of this industry the recent breakthroughs in proteomics and genomics have led to the development of modernized approaches to drug discovery and development in the industry for the possibility of newer advanced and more sophisticated therapies and drugs developments in biotechnology research have led to introduction of advanced therapies involving biopharmaceuticals regenerative medicine stem cells etc these new age therapies and products have caused ease of treatment procedures and enabled speedy recovery from various disorders technological growth in such interdisciplinary fields has opened up new arenas in drug discovery drug delivery and life sciences researchview less therapeuticsdiseases  treatmentclinical trialdietary supplementsbiopharmaceuticalspharmaceutical packagingpain managementpandemic vaccinebiosimilarpharmaceutical distributionover the counter otc druganesthesia drugscancer vaccinepharmaceutical technologyradiopharmaceuticalprescription drugspharmaceutical detailingclinical nutrition pharmaceuticals market research reports titlepublishedprice global onychomycosis tinea unguium drug detailed analysis report by qyresearch group oduct type by consumers and also their price change details as a detailed analysis report it covers all details inside analysis and opinion in onychomycosis tinea unguium drug industry this report focus global market it covers djul  united states vaginal pessary market report status and outlookby lp information inc  in united states market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smijul  united states tuberculin market report status and outlookby lp information inc r  in united states market the top players include sanofi pasteur zoetis par sterile ssi japan bcg thermo fisher sanroad biological cnbgjul  philippines vaginal pessary market report status and outlookby lp information inc in malaysia market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smiths medjul  philippines tuberculin market report status and outlookby lp information inc  in malaysia market the top players include sanofi pasteur zoetis par sterile ssi japan bcg thermo fisher sanroad biological cnbgjul  malaysia vaginal pessary market report status and outlookby lp information inc r  in malaysia market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smiths medicajul  malaysia tuberculin market report status and outlookby lp information inc in malaysia market the top players include sanofi pasteur zoetis par sterile ssi japan bcg thermo fisher sanroad biological cnbgjul  japan vaginal pessary market report status and outlookby lp information inc  in japan market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smiths medicaljul  japan tuberculin market report status and outlookby lp information inc trongin japan market the top players include sanofi pasteur zoetis par sterile ssi japan bcg thermo fisher sanroad biological cnbg jul  india vaginal pessary market report status and outlookby lp information inc  in india market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smiths medicaljul                 next » avail upto  discount on below publisher reports azoth analytics technavio page not found  medgadget  not found apologies but the page you requested could not be found perhaps searching will help at medgadget we report on the latest medical technology news interview leaders in the field and file dispatches from medical events from around the world about contact terms of service privacy submit press release advertise  medgadget llc  all rights reserved  the medical revolution will be blogged siga technologies inc  product pipeline review   sales and support     uk     us infomarketpublisherscom business  finance retail retail consumer goods food  beverage industry chemicals it  technology life sciences medical devices anesthesia  respiratory cardiovascular devices dental diabetes care diagnostic equipment drug delivery endoscopy ear nose  throat ent healthcare equipmentsupplies company reports implants neurology orthopedic ophthalmic surgical equipment wound closure other medical devices biotechnology biomarkers biomaterials biosimilars stem cell diagnostics  diseases in vitro diagnostics incontinence cancer cardiovascular diabetes hepatitis healthcare healthcare services company reports ear care eye care hospital medicated skin care therapy wound care pharmaceuticals clinical trial drug stores drugs pharmaceuticals company reports vaccines medical products veterinary services about faq my cart market reports pressreleases events about us terms  conditions customer faq market research reports life sciences pharmaceuticals siga technologies inc  product pipeline review   date september   pages  price us  license  singleuser license  us  site license  us  enterprisewide license  us  publisher global markets direct report type strategic report delivery email delivery pdf id sccfden leaflet download pdf leaflet abstracts contents list of tables list of figures siga technologies inc  product pipeline review  summaryglobal markets direct’s ‘siga technologies inc  product pipeline review  ’ provides an overview of the siga technologies inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of siga technologies inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of siga technologies inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of siga technologies inc’s human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the siga technologies inc’s pipeline productsreasons to buyevaluate siga technologies inc’s strategic position with total access to detailed information on its product pipelineassess the growth potential of siga technologies inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the siga technologies inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of siga technologies inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of siga technologies incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of siga technologies inc and identify potential opportunities in those areasavoid intellectual property rights related issues siga technologies inc snapshotsiga technologies inc overviewkey informationkey factssiga technologies inc  research and development overviewkey therapeutic areassiga technologies inc  pipeline reviewpipeline products by stage of developmentpipeline products  monotherapysiga technologies inc  pipeline products glancesiga technologies inc  late stage pipeline productsphase iii productscombination treatment modalitiessiga technologies inc  early stage pipeline productsindcta filed productscombination treatment modalitiespreclinical productscombination treatment modalitiesdiscovery productscombination treatment modalitiessiga technologies inc  drug profilestecovirimatproduct descriptionmechanism of actionrd progressstproduct descriptionmechanism of actionrd progressstproduct descriptionmechanism of actionrd progressstproduct descriptionmechanism of actionrd progressstproduct descriptionmechanism of actionrd progressstproduct descriptionmechanism of actionrd progresssiga technologies inc  pipeline analysissiga technologies inc  pipeline products by targetsiga technologies inc  pipeline products by route of administrationsiga technologies inc  pipeline products by molecule typesiga technologies inc  pipeline products by mechanism of actionsiga technologies inc  recent pipeline updatessiga technologies inc  dormant projectssiga technologies inc  locations and subsidiarieshead officeother locations  subsidiariesappendixmethodologycoveragesecondary researchprimary researchexpert panel validationcontact usdisclaimer list of tablessiga technologies inc key informationsiga technologies inc key factssiga technologies inc  pipeline by indication siga technologies inc  pipeline by stage of development siga technologies inc  monotherapy products in pipeline siga technologies inc  phase iii siga technologies inc  indcta filed siga technologies inc  preclinical siga technologies inc  discovery siga technologies inc  pipeline by target siga technologies inc  pipeline by route of administration siga technologies inc  pipeline by molecule type siga technologies inc  pipeline products by mechanism of action siga technologies inc  recent pipeline updates siga technologies inc  dormant developmental projectssiga technologies inc other locations list of figuressiga technologies inc  pipeline by top  indication siga technologies inc  pipeline by stage of development siga technologies inc  monotherapy products in pipeline siga technologies inc  pipeline by top  target siga technologies inc  pipeline by top  route of administration siga technologies inc  pipeline by top  molecule type siga technologies inc  pipeline products by top  mechanism of action  skip to top more publications adherex technologies inc  product pipeline review   us  apr  ·  pages armagen technologies inc  product pipeline review   us  apr  ·  pages multicell technologies inc  product pipeline review   us  apr  ·  pages medisyn technologies inc  product pipeline review   us  oct  ·  pages ask your question siga technologies inc  product pipeline review   company name contact person phonefax email request invoice your enquiry please click on a check box below to confirm you are not a robot market reports all categories biotechnology biomarkers biomaterials biosimilars stem cell diagnostics  diseases in vitro diagnostics incontinence cancer cardiovascular diabetes hepatitis healthcare healthcare services company reports ear care eye care hospital medicated skin care therapy wound care medical devices anesthesia  respiratory cardiovascular devices dental devices diabetes care diagnostic equipment drug delivery endoscopy ear nose  throat ent devices healthcare equipmentsupplies company reports neurology orthopedic devices ophthalmic surgical equipment wound closure other medical devices medical products pharmaceuticals clinical trials drug stores drugs pharmaceuticals company reports vaccines veterinary sales and support         infomarketpublisherscom   marketpublisherscom about us our clients our publishers customer faq market reports new publications reports by regions pressreleases terms  conditions privacy policy return policy affiliate program join as publisher follow us siga technologies inc  product pipeline review   about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in life sciences»pharmaceuticals»pharmaceuticals company reports siga technologies inc  product pipeline review   lowest prices guaranteed length publisher published date sku from   pages global markets direct september  gmd lowest prices guaranteed price from  length  pages publisher global markets direct published date september  sku gmd table of contents close window table of contents siga technologies inc  product pipeline review   printer format global markets direct siga technologies inc snapshot siga technologies inc overview key information key facts siga technologies inc  research and development overview key therapeutic areas siga technologies inc  pipeline review pipeline products by stage of development pipeline products  monotherapy siga technologies inc  pipeline products glance siga technologies inc  late stage pipeline products phase iii productscombination treatment modalities siga technologies inc  early stage pipeline products indcta filed productscombination treatment modalities preclinical productscombination treatment modalities discovery productscombination treatment modalities siga technologies inc  drug profiles tecovirimat product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress st product description mechanism of action rd progress siga technologies inc  pipeline analysis siga technologies inc  pipeline products by target siga technologies inc  pipeline products by route of administration siga technologies inc  pipeline products by molecule type siga technologies inc  pipeline products by mechanism of action siga technologies inc  recent pipeline updates siga technologies inc  dormant projects siga technologies inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablessiga technologies inc key information siga technologies inc key facts siga technologies inc  pipeline by indication  siga technologies inc  pipeline by stage of development  siga technologies inc  monotherapy products in pipeline  siga technologies inc  phase iii  siga technologies inc  indcta filed  siga technologies inc  preclinical  siga technologies inc  discovery  siga technologies inc  pipeline by target  siga technologies inc  pipeline by route of administration  siga technologies inc  pipeline by molecule type  siga technologies inc  pipeline products by mechanism of action  siga technologies inc  recent pipeline updates  siga technologies inc  dormant developmental projects siga technologies inc other locations list of figuressiga technologies inc  pipeline by top  indication  siga technologies inc  pipeline by stage of development  siga technologies inc  monotherapy products in pipeline  siga technologies inc  pipeline by top  target  siga technologies inc  pipeline by top  route of administration  siga technologies inc  pipeline by top  molecule type  siga technologies inc  pipeline products by top  mechanism of action  description close window description siga technologies inc  product pipeline review   printer format global markets direct siga technologies inc  product pipeline review  summaryglobal markets direct’s ‘siga technologies inc  product pipeline review  ’ provides an overview of the siga technologies inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of siga technologies inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of siga technologies inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of siga technologies inc’s human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones special feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statement latest news and deals relating to the siga technologies inc’s pipeline productsreasons to buyevaluate siga technologies inc’s strategic position with total access to detailed information on its product pipelineassess the growth potential of siga technologies inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the siga technologies inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of siga technologies inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of siga technologies incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of siga technologies inc and identify potential opportunities in those areasavoid intellectual property rights related issues search inside this report close window search inside this report online download  purchase site license  purchase global site license  purchase   research assistance us  intl  download our ebook how to succeed using market research learn how to effectively navigate the market research process to help guide your organization on the journey to success download ebook share this report other tasks printer format order by fax currency converter microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft siga technologies siga  stock predictions  price targets facebook autocomplete demo post a rating  month price target   home trending sign up log in siga technologies inc siga median target price  positive ratings  latest  zacks  underperform     view all analyst ratings for siga » facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising flashratings  principles facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings principles  flashratings mission is to provide you  the investor  with as much honest and professional research on your investments as possible  we believe its much better to get a multitude of credible opinions on an investment than to arbitrarily follow any single advisor  be it your banker a friend or a tv pundit  flashratings does not provide advice our job is to accurately and objectively report on analysts credible research and opinions the only advice flashratings will ever give you is to absorb as much fundamental research and different opinions as possible and make your own decisions  flashratings favors covering analysts with proven track records but will cover all analysts as long as their research is honest and professional sign up » siga technologies  wikipedia siga technologies from wikipedia the free encyclopedia jump to navigation search siga technologies inc type public traded as otc pink sigaq industry healthcare – biotechnology founded  headquarters new york city united states key people eric a rose md  chief executive officer and chairman daniel j luckshire  principal financial officer and chief financial officer dennis e hruby phd  chief scientific officer dec   revenue  m dec  number of employees  dec  website wwwsigacom siga technologies inc otc pink sigaq is a pharmaceutical company set up in  that is now based in new york city the company markets pharmaceutical solutions for smallpox ebola dengue lassa fever and other lethal diseasecausing pathogens contents  operations  history  products  services  awards  references  external links operationsedit siga has strong relationship with federal agencies and academic laboratories for its research and development activities siga is providing countermeasures to the strategic national stockpile sns and the department of defense dod such as category a pathogens using bsl or  work historyedit siga’s antiviral programs produce products to prevent pathogens and biodefense threats using the robotics in the chemical compound library the company’s bioinformatics infrastructure provides biological and chemical data and software platform for researchers to management and study such as data mining the current discovery targets are influenza virus hn hn bunyavirus rift valley fever virus la crosse virus filovirus marburg virus ebola virus flavivirus west nile virus in september  siga technologies received a  million research fund from the national institutes of health nih for its broadspectrum antiviral candidates in august  siga technologies was awarded a  million grant from the national institutes of health nih to develop an antiviral drug for treating and preventing lassa fever and others of arenavirus origin in  siga was ordered to pay  million in damages in a legal dispute with pharmathene over rights to the smallpox drug tecovirimat in july  siga technologies delivered about  courses of its smallpox antiviral drug tecovirimat arestvy to the united states governments strategic national stockpile sns meeting the requirement of governments biomedical advanced research and development authority barda in november  siga laid off its entire research  development division located in corvallis oregon the company liquidated all laboratory equipment at auction from that site siga is a member of the alliance for biosecurity the alliance is a publicprivate partnership and coalition of biopharmaceutical companies and academic organizations that promotes that works to ensure medical countermeasures are available to protect public health and improve national health security in  siga filed for bankruptcy protection products  servicesedit siga’s products include tecovirimat arestvyr st an orally administered antiviral drug for orthopoxviruses antiarenavirus drug for hemorrhagic fever classified as category a agents by the centers for disease control and prevention antiorthopoxvirus drug dengue antiviral broad spectrum antiviral screening for antivirals against category a and b pathogens awardsedit in  the company was selected as a winner of the deloitte new york new jersey connecticut technology fast  program for  as a fourtime winner of the reward referencesedit  company key statistics   company business summary   company with government relations   company research  discovery    million nih cooperative agreement supports siga broad spectrum antiviral research   siga awarded a  million grant for the development of antiviral drugs for arenaviruses   smallpox drug maker siga to mediate pharmathene dispute bloomberg news oct     siga meets drug delivery condition under barda contract and qualifies for first payment for delivering arestvyrtm   our members alliance for biosecurity retrieved    our mission alliance for biosecurity retrieved    siga technologies files for bankruptcy protection the wall street journal sep     company full description   siga technologies named to deloitte tristate area technology fast   external linksedit official website retrieved from httpsenwikipediaorgwindexphptitlesigatechnologiesoldid categories companies formerly listed on nasdaqcompanies that filed for chapter  bankruptcy in hidden categories pages using infobox company with unsupported parameters navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view creative commons — attributionsharealike  unported — cc bysa  skip to content menu help us build a vibrant collaborative global commons donate now creative commons creative commons license deed attributionsharealike  unported cc bysa  this is a humanreadable summary of and not a substitute for the license disclaimer you are free to share — copy and redistribute the material in any medium or format adapt — remix transform and build upon the material for any purpose even commercially the licensor cannot revoke these freedoms as long as you follow the license terms under the following terms attribution — you must give appropriate credit provide a link to the license and indicate if changes were made you may do so in any reasonable manner but not in any way that suggests the licensor endorses you or your use attribute this work sharealike — if you remix transform or build upon the material you must distribute your contributions under the same license as the original no additional restrictions — you may not apply legal terms or technological measures that legally restrict others from doing anything the license permits notices you do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation no warranties are given the license may not give you all of the permissions necessary for your intended use for example other rights such as publicity privacy or moral rights may limit how you use the material learn more about cc licensing or use the license for your own material this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work make a donation this page is available in the following languages castellano castellano españa català dansk deutsch english esperanto français galego hrvatski indonesia italiano latviski lietuvių melayu nederlands norsk polski português português br română slovenščina suomeksi svenska türkçe íslenska česky ελληνικά беларуская русский українська العربية پارسی     한국어 this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work when you share everyone wins contribute today to creative commons     disclaimer this deed highlights only some of the key features and terms of the actual license it is not a license and has no legal value you should carefully review all of the terms and conditions of the actual license before using the licensed material creative commons is not a law firm and does not provide legal services distributing displaying or linking to this deed or the license that it summarizes does not create a lawyerclient or any other relationship what does attribute this work mean the page you came from contained embedded licensing metadata including how the creator wishes to be attributed for reuse you can use the html here to cite the work doing so will also include metadata on your page so that others can find the original work as well the applicable mediation rules will be designated in the copyright notice published with the work or if none then in the request for mediation unless otherwise designated in a copyright notice attached to the work the uncitral arbitration rules apply to any arbitration more info if supplied you must provide the name of the creator and attribution parties a copyright notice a license notice a disclaimer notice and a link to the material cc licenses prior to version  also require you to provide the title of the material if supplied and may have other slight differences more info in  you must indicate if you modified the material and retain an indication of previous modifications in  and earlier license versions the indication of changes is only required if you create a derivative marking guide more info you may also use a license listed as compatible at httpscreativecommonsorgcompatiblelicenses more info a commercial use is one primarily intended for commercial advantage or monetary compensation more info merely changing the format never creates a derivative more info the license prohibits application of effective technological measures defined with reference to article  of the wipo copyright treaty more info the rights of users under exceptions and limitations such as fair use and fair dealing are not affected by the cc licenses more info you may need to get additional permissions before using the material as you intend more info siga technologies  wikipedia siga technologies from wikipedia the free encyclopedia jump to navigation search siga technologies inc type public traded as otc pink sigaq industry healthcare – biotechnology founded  headquarters new york city united states key people eric a rose md  chief executive officer and chairman daniel j luckshire  principal financial officer and chief financial officer dennis e hruby phd  chief scientific officer dec   revenue  m dec  number of employees  dec  website wwwsigacom siga technologies inc otc pink sigaq is a pharmaceutical company set up in  that is now based in new york city the company markets pharmaceutical solutions for smallpox ebola dengue lassa fever and other lethal diseasecausing pathogens contents  operations  history  products  services  awards  references  external links operationsedit siga has strong relationship with federal agencies and academic laboratories for its research and development activities siga is providing countermeasures to the strategic national stockpile sns and the department of defense dod such as category a pathogens using bsl or  work historyedit siga’s antiviral programs produce products to prevent pathogens and biodefense threats using the robotics in the chemical compound library the company’s bioinformatics infrastructure provides biological and chemical data and software platform for researchers to management and study such as data mining the current discovery targets are influenza virus hn hn bunyavirus rift valley fever virus la crosse virus filovirus marburg virus ebola virus flavivirus west nile virus in september  siga technologies received a  million research fund from the national institutes of health nih for its broadspectrum antiviral candidates in august  siga technologies was awarded a  million grant from the national institutes of health nih to develop an antiviral drug for treating and preventing lassa fever and others of arenavirus origin in  siga was ordered to pay  million in damages in a legal dispute with pharmathene over rights to the smallpox drug tecovirimat in july  siga technologies delivered about  courses of its smallpox antiviral drug tecovirimat arestvy to the united states governments strategic national stockpile sns meeting the requirement of governments biomedical advanced research and development authority barda in november  siga laid off its entire research  development division located in corvallis oregon the company liquidated all laboratory equipment at auction from that site siga is a member of the alliance for biosecurity the alliance is a publicprivate partnership and coalition of biopharmaceutical companies and academic organizations that promotes that works to ensure medical countermeasures are available to protect public health and improve national health security in  siga filed for bankruptcy protection products  servicesedit siga’s products include tecovirimat arestvyr st an orally administered antiviral drug for orthopoxviruses antiarenavirus drug for hemorrhagic fever classified as category a agents by the centers for disease control and prevention antiorthopoxvirus drug dengue antiviral broad spectrum antiviral screening for antivirals against category a and b pathogens awardsedit in  the company was selected as a winner of the deloitte new york new jersey connecticut technology fast  program for  as a fourtime winner of the reward referencesedit  company key statistics   company business summary   company with government relations   company research  discovery    million nih cooperative agreement supports siga broad spectrum antiviral research   siga awarded a  million grant for the development of antiviral drugs for arenaviruses   smallpox drug maker siga to mediate pharmathene dispute bloomberg news oct     siga meets drug delivery condition under barda contract and qualifies for first payment for delivering arestvyrtm   our members alliance for biosecurity retrieved    our mission alliance for biosecurity retrieved    siga technologies files for bankruptcy protection the wall street journal sep     company full description   siga technologies named to deloitte tristate area technology fast   external linksedit official website retrieved from httpsenwikipediaorgwindexphptitlesigatechnologiesoldid categories companies formerly listed on nasdaqcompanies that filed for chapter  bankruptcy in hidden categories pages using infobox company with unsupported parameters navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view siga technologies  linkedin linkedin main content starts below siga technologies  wikipedia siga technologies from wikipedia the free encyclopedia jump to navigation search siga technologies inc type public traded as otc pink sigaq industry healthcare – biotechnology founded  headquarters new york city united states key people eric a rose md  chief executive officer and chairman daniel j luckshire  principal financial officer and chief financial officer dennis e hruby phd  chief scientific officer dec   revenue  m dec  number of employees  dec  website wwwsigacom siga technologies inc otc pink sigaq is a pharmaceutical company set up in  that is now based in new york city the company markets pharmaceutical solutions for smallpox ebola dengue lassa fever and other lethal diseasecausing pathogens contents  operations  history  products  services  awards  references  external links operationsedit siga has strong relationship with federal agencies and academic laboratories for its research and development activities siga is providing countermeasures to the strategic national stockpile sns and the department of defense dod such as category a pathogens using bsl or  work historyedit siga’s antiviral programs produce products to prevent pathogens and biodefense threats using the robotics in the chemical compound library the company’s bioinformatics infrastructure provides biological and chemical data and software platform for researchers to management and study such as data mining the current discovery targets are influenza virus hn hn bunyavirus rift valley fever virus la crosse virus filovirus marburg virus ebola virus flavivirus west nile virus in september  siga technologies received a  million research fund from the national institutes of health nih for its broadspectrum antiviral candidates in august  siga technologies was awarded a  million grant from the national institutes of health nih to develop an antiviral drug for treating and preventing lassa fever and others of arenavirus origin in  siga was ordered to pay  million in damages in a legal dispute with pharmathene over rights to the smallpox drug tecovirimat in july  siga technologies delivered about  courses of its smallpox antiviral drug tecovirimat arestvy to the united states governments strategic national stockpile sns meeting the requirement of governments biomedical advanced research and development authority barda in november  siga laid off its entire research  development division located in corvallis oregon the company liquidated all laboratory equipment at auction from that site siga is a member of the alliance for biosecurity the alliance is a publicprivate partnership and coalition of biopharmaceutical companies and academic organizations that promotes that works to ensure medical countermeasures are available to protect public health and improve national health security in  siga filed for bankruptcy protection products  servicesedit siga’s products include tecovirimat arestvyr st an orally administered antiviral drug for orthopoxviruses antiarenavirus drug for hemorrhagic fever classified as category a agents by the centers for disease control and prevention antiorthopoxvirus drug dengue antiviral broad spectrum antiviral screening for antivirals against category a and b pathogens awardsedit in  the company was selected as a winner of the deloitte new york new jersey connecticut technology fast  program for  as a fourtime winner of the reward referencesedit  company key statistics   company business summary   company with government relations   company research  discovery    million nih cooperative agreement supports siga broad spectrum antiviral research   siga awarded a  million grant for the development of antiviral drugs for arenaviruses   smallpox drug maker siga to mediate pharmathene dispute bloomberg news oct     siga meets drug delivery condition under barda contract and qualifies for first payment for delivering arestvyrtm   our members alliance for biosecurity retrieved    our mission alliance for biosecurity retrieved    siga technologies files for bankruptcy protection the wall street journal sep     company full description   siga technologies named to deloitte tristate area technology fast   external linksedit official website retrieved from httpsenwikipediaorgwindexphptitlesigatechnologiesoldid categories companies formerly listed on nasdaqcompanies that filed for chapter  bankruptcy in hidden categories pages using infobox company with unsupported parameters navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view